"FDA bioequivalence standards" - Information and Links:

FDA bioequivalence standards - Info and Reading Options

"FDA bioequivalence standards" was published by AAPS Press/Springer in 2014 - New York, it has 465 pages and the language of the book is English.


“FDA bioequivalence standards” Metadata:

  • Title: FDA bioequivalence standards
  • Authors:
  • Language: English
  • Number of Pages: 465
  • Publisher: AAPS Press/Springer
  • Publish Date:
  • Publish Location: New York

“FDA bioequivalence standards” Subjects and Themes:

Edition Specifications:

  • Pagination: xiii, 465 pages

Edition Identifiers:

AI-generated Review of “FDA bioequivalence standards”:


"FDA bioequivalence standards" Table Of Contents:

  • 1- 1 Bioequivalence History
  • 2- 2 Fundamentals of Bioequivalence
  • 3- 3 Basic Statistical Considerations
  • 4- 4 The Effects of Food on Drug Bioavailability and Bioequivalence
  • 5- 5 Bio waiver and Biopharmaceutics Classification System
  • 6- 6 Bioequivalence of Highly Variable Drugs
  • 7- 7 Partial Area under the Curve: An Additional Pharmacokinetic Metric for Bioavailability and Bioequivalence Assessments
  • 8- 8 Bioequivalence for Narrow Therapeutic Index Drugs
  • 9- 9 Pharmacodynamic Endpoint-based Bioequivalence Studies
  • 10- 10 Clinical Endpoint Bioequivalence Study
  • 11- 11 Bioequivalence for Liposomal Drug Products
  • 12- 12 Bioequivalence for Drug Products Acting Locally within Gastrointestinal Tract
  • 13- 13 Bioequivalence for Topical Drug Products
  • 14- 14 Bioequivalence for Orally Inhaled and Nasal Drug Products
  • 15- 15 Bioequivalence: Modeling and Simulation
  • 16- 16 Bioanalysis.

"FDA bioequivalence standards" Description:

The Open Library:

This comprehensive reference provides an in-depth discussion on state-of-the-art regulatory science in bioequivalence. In sixteen chapters, the volume explores a broad range of topics pertaining to bioequivalence, including its origin and principles, statistical considerations, food effect studies, conditions for waivers of bioequivalence studies, Biopharmaceutics Classification Systems, Biopharmaceutics Drug Disposition Classification System, bioequivalence modeling/simulation, and best practices in bioanalysis. It also discusses bioequivalence studies with pharmacodynamic and clinical endpoints as well as bioequivalence approaches for highly variable drugs, narrow therapeutic index drugs, liposomes, locally acting gastrointestinal drug products, topical products, and nasal and inhalation products. FDA Bioequivalence Standards is written by FDA regulatory scientists who develop regulatory policies and conduct regulatory assessment of bioequivalence. As such, both practical case studies and fundamental science are highlighted in these chapters. The book is a valuable resource for scientists who work in the pharmaceutical industry, regulatory agencies, and academia as well as undergraduate and graduate students looking to expand their knowledge about bioequivalence standards.--

Read “FDA bioequivalence standards”:

Read “FDA bioequivalence standards” by choosing from the options below.

Search for “FDA bioequivalence standards” downloads:

Visit our Downloads Search page to see if downloads are available.

Find “FDA bioequivalence standards” in Libraries Near You:

Read or borrow “FDA bioequivalence standards” from your local library.

Buy “FDA bioequivalence standards” online:

Shop for “FDA bioequivalence standards” on popular online marketplaces.



Find "FDA Bioequivalence Standards" in Wikipdedia